Palatin Technologies Inc (PTN)
1.20
-0.04
(-3.23%)
USD |
NYAM |
Nov 01, 16:00
1.19
-0.01
(-0.83%)
After-Hours: 20:00
Palatin Technologies Enterprise Value: 13.93M for Nov. 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 13.93M |
| October 31, 2024 | 14.71M |
| October 30, 2024 | 15.10M |
| October 29, 2024 | 12.95M |
| October 28, 2024 | 14.13M |
| October 25, 2024 | 11.78M |
| October 24, 2024 | 11.98M |
| October 23, 2024 | 11.78M |
| October 22, 2024 | 11.00M |
| October 21, 2024 | 10.22M |
| October 18, 2024 | 9.630M |
| October 17, 2024 | 10.02M |
| October 16, 2024 | 8.848M |
| October 15, 2024 | 7.558M |
| October 14, 2024 | 7.421M |
| October 11, 2024 | 7.677M |
| October 10, 2024 | 7.673M |
| October 09, 2024 | 7.740M |
| October 08, 2024 | 7.497M |
| October 07, 2024 | 8.262M |
| October 04, 2024 | 7.736M |
| October 03, 2024 | 6.659M |
| October 02, 2024 | 6.502M |
| October 01, 2024 | 7.675M |
| September 30, 2024 | 7.957M |
| Date | Value |
|---|---|
| September 27, 2024 | 6.905M |
| September 26, 2024 | 8.824M |
| September 25, 2024 | 9.083M |
| September 24, 2024 | 10.23M |
| September 23, 2024 | 13.91M |
| September 20, 2024 | 15.27M |
| September 19, 2024 | 15.46M |
| September 18, 2024 | 16.82M |
| September 17, 2024 | 17.01M |
| September 16, 2024 | 17.40M |
| September 13, 2024 | 19.14M |
| September 12, 2024 | 19.14M |
| September 11, 2024 | 18.17M |
| September 10, 2024 | 18.75M |
| September 09, 2024 | 19.33M |
| September 06, 2024 | 19.14M |
| September 05, 2024 | 19.91M |
| September 04, 2024 | 18.85M |
| September 03, 2024 | 19.72M |
| August 30, 2024 | 22.05M |
| August 29, 2024 | 20.88M |
| August 28, 2024 | 22.05M |
| August 27, 2024 | 19.33M |
| August 26, 2024 | 22.43M |
| August 23, 2024 | 20.30M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-8.910M
Minimum
Mar 18 2020
215.39M
Maximum
Feb 10 2021
38.31M
Average
30.05M
Median
Feb 28 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 3.615M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.69M |
| Oragenics Inc | 1.901M |
| Nanoviricides Inc | 16.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.250M |
| Revenue (Quarterly) | 0.35M |
| Total Expenses (Quarterly) | 8.676M |
| EPS Diluted (Quarterly) | -0.49 |
| Profit Margin (Quarterly) | -2.36K% |
| Earnings Yield | -171.7% |
| Normalized Earnings Yield | -174.72 |